semaglutide and bladder cancer Diabetes Medications Risk: A Critical Review Daniel Flora: Weight-Loss Drugs and

Mediterranean-style stuffed zucchini boats with ground turkey, tomatoes, and herbs, served with a side salad

Value-Based Agreements for GLP-1 Anti-Obesity Medicines in Medicare Antiobesity medicines (AOMs), including GLP1 agonists, offer substantial promise for curbing chronic disease in the U.S

or oral compounds inhibiting dipeptidyl peptidase-4 (DPP-4), the enzyme that inactives GLP-1, also called gliptins (Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Alogliptin)

It supports the release of insulin to lower blood sugar without causing it to drop too low

A recent study treating ex vivo isolated human bronchi with exendin-4 demonstrated a positive GLP-1R immunostaining pattern in key airway structures, including the epithelium, bronchial cilia, mucous glands, inflammatory cells, and the ASM of medium-sized bronchi (Figure 5A)